Furthermore, tumor-infiltrating granulocytes in patients with non-small cell lung cancer or renal cell carcinoma have decreased ARG1 levels compared to their non-tumor-infiltrating counterparts (126, 134), despite having increased ARG1 mRNA expression (126). This evidence concerns the gene ARG1 and hereditary clear cell renal cell carcinoma.